Clinical Trial Update: Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating tranexamic acid to prevent growth of acute intracerebral hemorrhage identified by spot sign.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Ministry of Science and Technology of the People´s Republic of China | Conditions: Intracerebral Hemorrhage, Stroke | Phase 2 | Status: UNKNOWN